Cite
The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia.
MLA
Alegretti, Ana Paula, et al. “The Expression of CD56 Antigen Is Associated with Poor Prognosis in Patients with Acute Myeloid Leukemia.” Revista Brasileira de Hematologia e Hemoterapia, vol. 33, no. 3, 2011, pp. 202–06. EBSCOhost, https://doi.org/10.5581/1516-8484.20110054.
APA
Alegretti, A. P., Bittar, C. M., Bittencourt, R., Piccoli, A. K., Schneider, L., Silla, L. M., Bó, S. D., & Xavier, R. M. (2011). The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia. Revista Brasileira de Hematologia e Hemoterapia, 33(3), 202–206. https://doi.org/10.5581/1516-8484.20110054
Chicago
Alegretti, Ana Paula, Christina Matzenbacher Bittar, Rosane Bittencourt, Amanda Kirchner Piccoli, Laiana Schneider, Lúcia Mariano Silla, Suzane Dal Bó, and Ricardo Machado Xavier. 2011. “The Expression of CD56 Antigen Is Associated with Poor Prognosis in Patients with Acute Myeloid Leukemia.” Revista Brasileira de Hematologia e Hemoterapia 33 (3): 202–6. doi:10.5581/1516-8484.20110054.